These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22225506)

  • 1. The withdrawal of Activated Protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation].
    Thachil J; Toh CH; Levi M; Watson HG
    Br J Haematol; 2012 May; 157(4):493-4. PubMed ID: 22225506
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
    Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical practice. DIC 2002: a review of disseminated intravascular coagulation.
    Toh CH; Dennis M
    Hematology; 2003 Apr; 8(2):65-71. PubMed ID: 12745654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation.
    Iba T; Nagaoka I; Boulat M
    Thromb Res; 2013 May; 131(5):383-9. PubMed ID: 23566533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
    Maruyama I
    Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation in sepsis: all bugs bite equally.
    Levi M; van der Poll T
    Crit Care; 2004 Apr; 8(2):99-100. PubMed ID: 15025767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human activated protein C in the treatment of severe sepsis: an evidence-based review.
    Fourrier F
    Crit Care Med; 2004 Nov; 32(11 Suppl):S534-41. PubMed ID: 15542961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activated protein C].
    Uchiba M
    Rinsho Byori; 2011 Feb; Suppl 147():171-6. PubMed ID: 21761767
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe sepsis, coagulation, and fibrinolysis: dead end or one way?
    Fourrier F
    Crit Care Med; 2012 Sep; 40(9):2704-8. PubMed ID: 22732284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
    Maruyama I
    Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation and sepsis: a winding road ahead.
    Levi M
    Crit Care Med; 2012 Sep; 40(9):2733-4. PubMed ID: 22903108
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion on applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis.
    Radenkovic DV; Bajec DD; Karamarkovic AR
    Pancreas; 2006 Jul; 33(1):106-7; author reply 107-8. PubMed ID: 16804422
    [No Abstract]   [Full Text] [Related]  

  • 17. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S90-4. PubMed ID: 11445740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    van Zanten AR; Bakker J; van den Berg PC; Girbes AR; van Leeuwen SJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(24):1179. PubMed ID: 11433670
    [No Abstract]   [Full Text] [Related]  

  • 19. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of plasma-derived protein C for treating disseminated intravascular coagulation in adult patients with active cancer.
    Malato A; Saccullo G; Coco LL; Caracciolo C; Raso S; Santoro M; Zammit V; Siragusa S
    Am J Hematol; 2012 Feb; 87(2):230-2. PubMed ID: 22228308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.